Cargando…

Pathogenesis and Diagnostic Significance of EBV-miR-BARTs in Nasopharyngeal Carcinoma

OBJECTIVE: Examining the role of EBV-miR-BARTs in nasopharyngeal cancer etiology and diagnosis. METHOD: As the subjects of this study, nasopharyngeal cancer cell lines were chosen and then randomly assigned to one of four groups: the control group, EBV-miR-BART5-3p NC, EBV-miR-BART5-3p mimics, and E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zhen, Zhang, Xiaoling, Liu, Pinjing, Wei, Aiyou, Ouyang, Wei, Xiao, Shengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550407/ https://www.ncbi.nlm.nih.gov/pubmed/36225172 http://dx.doi.org/10.1155/2022/4479905

Ejemplares similares

EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC
por: Yan, Qijia, et al.
Publicado: (2015)

EBV-miR-BART7-3p Imposes Stemness in Nasopharyngeal Carcinoma Cells by Suppressing SMAD7
por: Cai, Longmei, et al.
Publicado: (2019)

Circulation EBV Mir-Bart-7 Relating to Clinical Manifestation in Nasopharyngeal Carcinoma
por: Wardana, Tirta, et al.
Publicado: (2020)

Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma
por: Cai, Longmei, et al.
Publicado: (2015)

Dissecting the regulation of EBV’s BART miRNAs in carcinomas
por: Yang, Ya-Chun, et al.
Publicado: (2017)

miR-4721, Induced by EBV-miR-BART22, Targets GSK3β to Enhance the Tumorigenic Capacity of NPC through the WNT/β-catenin Pathway
por: Tang, ZiBo, et al.
Publicado: (2020)

EBV miR-BART10-3p Promotes Cell Proliferation and Migration by Targeting DKK1
por: Min, Kyoungmi, et al.
Publicado: (2019)

BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma
por: Wang, Youhong, et al.
Publicado: (2017)

Vesicle‐bound EBV‐BART13‐3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV‐infections
por: Ramayanti, Octavia, et al.
Publicado: (2018)

EBV-Mir-BART5-5p targets p53 independent pathway in cytoplasm: Potential role in EBV lymphomagenesis
por: Wang, Wei-Ting, et al.
Publicado: (2022)

Effects of Co-Culture EBV-miR-BART1-3p on Proliferation and Invasion of Gastric Cancer Cells Based on Exosomes
por: Lin, Mengyao, et al.
Publicado: (2023)

EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma
por: Lyu, Xiaoming, et al.
Publicado: (2018)

Downregulation of ABI2 expression by EBV-miR-BART13-3p induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells through upregulation of c-JUN/SLUG signaling
por: Huang, Jing, et al.
Publicado: (2020)

EBV encoded miRNA BART8-3p promotes radioresistance in nasopharyngeal carcinoma by regulating ATM/ATR signaling pathway
por: Zhou, Xiaohan, et al.
Publicado: (2019)

Targeting the Ca(2 +) Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome
por: Gallo, Alessia, et al.
Publicado: (2016)

miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis
por: Cheung, Chartia Ching-Mei, et al.
Publicado: (2014)

EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways
por: Lin, Cheng, et al.
Publicado: (2018)

Correction: EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma
por: Lyu, Xiaoming, et al.
Publicado: (2020)

EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1
por: Wang, Jie, et al.
Publicado: (2022)

Correction to: EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways
por: Lin, Cheng, et al.
Publicado: (2019)

Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells
por: Gourzones, Claire, et al.
Publicado: (2010)

Targeting exosomes enveloped EBV‐miR‐BART1‐5p‐antagomiRs for NPC therapy through both anti‐vasculogenic mimicry and anti‐angiogenesis
por: Wang, Jianguo, et al.
Publicado: (2023)

The Epstein-Barr Virus-Encoded MicroRNA MiR-BART9 Promotes Tumor Metastasis by Targeting E-Cadherin in Nasopharyngeal Carcinoma
por: Hsu, Chung-Yuan, et al.
Publicado: (2014)

Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1
por: Song, Yali, et al.
Publicado: (2016)

The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma
por: Chen, Ruichao, et al.
Publicado: (2017)

Epstein–Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1
por: Wu, Yangge, et al.
Publicado: (2023)

Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma
por: Zheng, Xiao-Hui, et al.
Publicado: (2015)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

Retraction: The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma
por: Chen, Ruichao, et al.
Publicado: (2017)

Expression of miR-30c and miR-29b in prostate cancer and its diagnostic significance
por: Zhu, Chuanan, et al.
Publicado: (2018)

The Oncogenic Role of miR-BART19-3p in Epstein-Barr Virus-Associated Diseases
por: Zhang, Qingxun, et al.
Publicado: (2020)

Potential Interest in Circulating miR-BART17-5p As a Post-Treatment Biomarker for Prediction of Recurrence in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma
por: Hirai, Nobuyuki, et al.
Publicado: (2016)

Epstein-Barr Virus miR-BART1-3p Regulates the miR-17-92 Cluster by Targeting E2F3
por: Park, Myung Chan, et al.
Publicado: (2021)

Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer
por: De Re, Valli, et al.
Publicado: (2020)

EBV-Encoded MicroRNA-BART17-3p Targets DDX3X and Promotes EBV Infection in EBV-Associated T/Natural Killer–Cell Lymphoproliferative Diseases
por: Jin, Jin, et al.
Publicado: (2023)

Functional elucidation of miR-494 in the tumorigenesis of nasopharyngeal carcinoma
por: Duan, Hong-Fang, et al.
Publicado: (2015)

The diagnostic value of EBV-DNA and EBV-related antibodies detection for nasopharyngeal carcinoma: a meta-analysis
por: Liu, Weixing, et al.
Publicado: (2021)

Diagnostic and Prognostic Significance of miR-675-3p in Patients With Atherosclerosis
por: Wang, Shuangquan, et al.
Publicado: (2021)

EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis
por: Ma, J, et al.
Publicado: (2016)

As Evidence-Based Tumorigenic Role of Epstein-Barr Virus miR-BART1-3p in Neurological Tumors
por: Karimzadeh, Mohammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1j0opd6qpkfet7auha0tr8j8cr